First Clinical Real-World Evidence And Patient Satisfaction Outcomes After Implantation Of Non-Diffractive Rayner Rayone Emv Toric Enhanced Monofocal Iol In Polish Patients

Published 2023 - 41st Congress of the ESCRS

Reference: PO0434 | DOI: 10.82333/ttxr-ew13

Authors: Piotr Berezowski* ¹ , Adam Kabiesz ¹

¹Ophthalmology,Beskidzkie Centrum Medyczne,Bielsko-Biała,Poland

To investigate first Real-World Evidence clinical outcomes in Polish cataract patients with pre-
operative corneal astigmatism and mild pathologies implanted with non-diffractive Rayner
RayOne EMV Toric Intraocular lenses (IOL) RAO210T.

Beskidzkie Centrum Medyczne - Bielsko Biała, Poland

This ongoing data collection currently comprises clinical outcomes of 12 eyes (7 patients) that
were implanted with the Rayner RayOne EMV Toric IOL. Patients presented with cataract,
corneal astigmatism (Mean (SD): 2.50 ±0.59 D of corneal astigmatism (range: 1.73 to 3.47 D)
as well as mild pathologies including amblyopia, glaucoma, AMD and one patient with Fuchs
heterochromic iridocyclites. All patients were targeted for mini-monovision of ±0.25 D. The
following parameters were collected one month postoperatively: objective refraction, monocular
and binocular UDVA, as well as CDVA. In addition, intraoperative and postoperative observations of the surgeon as well
as patients’ satisfaction and spectacle independence were collected.

Based on the available interim outcomes, the refractive cylinder significantly decreased from

2.46±1.46 D preoperatively to 0.92±0.42 D postoperatively (p<0.001). Mean monocular and

binocular UDVA were 0.13±0.11 and 0.05±0.07 logMAR, respectively. The according monocular

CDVA was 0.11±0.10 logMAR. 92% of the patients were very satisfied and 8% were satisfied

with their vision. On one IOL, a slight rotation of less then 5° was observed without the need of

repositioning. All other IOLs showed no visible change in placement. Photic phenomena were

neither reported for daytime nor nighttime activities. Spectacle use was only indicated for near

tasks.

Based on the first results of this ongoing real world evidence data analysis, we conclude, that a
bilateral implantation of RayOne EMV Toric IOLs using a mini-monovision approach leads to
very satisfying visual acuity outcomes for this patient group with mild pathologies, still achieving
a broad range of vision. In addition, the pre-existing refractive cylinder is significantly decreased.
Subjective outcomes for both, surgeon and patient, confirm a stable IOL platform and very high
satisfaction rate, especially for the achieved near vision results with no reported visual side
effects.